• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Malignant Mesothelioma: Time to Translate?恶性间皮瘤:是时候进行翻译了吗?
Trends Cancer. 2016 Sep;2(9):467-474. doi: 10.1016/j.trecan.2016.07.004.
2
Systemic approach to malignant pleural mesothelioma: what news of chemotherapy, targeted agents and immunotherapy?恶性胸膜间皮瘤的系统治疗方法:化疗、靶向药物及免疫治疗有哪些新进展?
Tumori. 2016 Jan-Feb;102(1):18-30. doi: 10.5301/tj.5000436. Epub 2015 Oct 14.
3
HMGB1 as a Potential Biomarker and Therapeutic Target for Malignant Mesothelioma.HMGB1 作为恶性间皮瘤的潜在生物标志物和治疗靶点。
Dis Markers. 2019 Feb 12;2019:4183157. doi: 10.1155/2019/4183157. eCollection 2019.
4
The resistance related to targeted therapy in malignant pleural mesothelioma: Why has not the target been hit yet?恶性胸膜间皮瘤靶向治疗相关耐药性:为何尚未命中靶点?
Crit Rev Oncol Hematol. 2016 Nov;107:20-32. doi: 10.1016/j.critrevonc.2016.08.011. Epub 2016 Sep 1.
5
Absence of germline mutations in BAP1 in sporadic cases of malignant mesothelioma.散发性恶性间皮瘤病例中BAP1种系突变的缺失。
Gene. 2015 May 25;563(1):103-5. doi: 10.1016/j.gene.2015.03.031. Epub 2015 Mar 18.
6
NF2/Merlin Inactivation and Potential Therapeutic Targets in Mesothelioma.神经纤维瘤病 2 型/ Merlin 失活与间皮瘤的潜在治疗靶点。
Int J Mol Sci. 2018 Mar 26;19(4):988. doi: 10.3390/ijms19040988.
7
Puzzling Results from Germline Mutations Analysis in a Group of Asbestos-Exposed Patients in a High-risk Area of Northeast Italy.意大利东北部高危地区一组石棉暴露患者生殖系突变分析的令人困惑的结果
Anticancer Res. 2017 Jun;37(6):3073-3083. doi: 10.21873/anticanres.11663.
8
Consensus Report of the 2015 Weinman International Conference on Mesothelioma.2015年温曼国际间皮瘤会议共识报告
J Thorac Oncol. 2016 Aug;11(8):1246-1262. doi: 10.1016/j.jtho.2016.04.028.
9
BAP1 gene mutations in Egyptian patients with advanced sporadic malignant pleural mesothelioma (MPM): relation with clinical outcomes and survival.埃及晚期散发性恶性胸膜间皮瘤(MPM)患者的BAP1基因突变:与临床结局和生存的关系
Cancer Genet. 2018 Dec;228-229:83-92. doi: 10.1016/j.cancergen.2018.10.001. Epub 2018 Oct 8.
10
Germline BAP1 Mutational Landscape of Asbestos-Exposed Malignant Mesothelioma Patients with Family History of Cancer.有癌症家族史的石棉暴露恶性间皮瘤患者的种系BAP1突变图谱
Cancer Res. 2016 Jan 15;76(2):206-15. doi: 10.1158/0008-5472.CAN-15-0295. Epub 2015 Dec 30.

引用本文的文献

1
The epidemic of malignant mesothelioma in China: a prediction of incidence during 2016-2030.中国恶性间皮瘤的流行情况:2016 - 2030年发病率预测
Transl Lung Cancer Res. 2022 Dec;11(12):2403-2411. doi: 10.21037/tlcr-22-233.
2
Organoids as a Model for Precision Medicine in Malignant Pleural Mesothelioma: Where Are We Today?类器官作为恶性胸膜间皮瘤精准医学的模型:我们目前进展如何?
Cancers (Basel). 2022 Aug 2;14(15):3758. doi: 10.3390/cancers14153758.
3
An Unpleasant Surprise: Abdominal Presentation of Malignant Mesothelioma.一个不愉快的意外:恶性间皮瘤的腹部表现。
J Investig Med High Impact Case Rep. 2020 Jan-Dec;8:2324709620950121. doi: 10.1177/2324709620950121.
4
Consensus report of the 8 and 9th Weinman Symposia on Gene x Environment Interaction in carcinogenesis: novel opportunities for precision medicine.第 8 届和第 9 届 Weinman 基因-环境相互作用致癌作用研讨会共识报告:精准医学的新机遇。
Cell Death Differ. 2018 Nov;25(11):1885-1904. doi: 10.1038/s41418-018-0213-5. Epub 2018 Oct 15.
5
The Cappadocia mesothelioma epidemic: its influence in Turkey and abroad.卡帕多西亚间皮瘤疫情:其在土耳其国内外的影响。
Ann Transl Med. 2017 Jun;5(11):239. doi: 10.21037/atm.2017.04.06.
6
FTY720 inhibits mesothelioma growth in vitro and in a syngeneic mouse model.FTY720在体外和同基因小鼠模型中抑制间皮瘤生长。
J Transl Med. 2017 Mar 15;15(1):58. doi: 10.1186/s12967-017-1158-z.
7
Improving the Accuracy of Mesothelioma Diagnosis in China.提高中国间皮瘤诊断的准确性。
J Thorac Oncol. 2017 Apr;12(4):714-723. doi: 10.1016/j.jtho.2016.12.006. Epub 2016 Dec 19.
8
High-density array-CGH with targeted NGS unmask multiple noncontiguous minute deletions on chromosome 3p21 in mesothelioma.采用靶向二代测序的高密度阵列比较基因组杂交技术揭示了间皮瘤中3号染色体短臂21区多个不连续的微小缺失。
Proc Natl Acad Sci U S A. 2016 Nov 22;113(47):13432-13437. doi: 10.1073/pnas.1612074113. Epub 2016 Nov 9.

本文引用的文献

1
Consensus Report of the 2015 Weinman International Conference on Mesothelioma.2015年温曼国际间皮瘤会议共识报告
J Thorac Oncol. 2016 Aug;11(8):1246-1262. doi: 10.1016/j.jtho.2016.04.028.
2
Genome-based Mutational Analysis by Next Generation Sequencing in Patients with Malignant Pleural and Peritoneal Mesothelioma.基于基因组的恶性胸膜和腹膜间皮瘤患者下一代测序突变分析
Anticancer Res. 2016 May;36(5):2331-8.
3
Evaluation of New Biomarkers in the Prediction of Malignant Mesothelioma in Subjects with Environmental Asbestos Exposure.评估新生物标志物对环境石棉暴露人群恶性间皮瘤的预测价值。
Lung. 2016 Jun;194(3):409-17. doi: 10.1007/s00408-016-9868-1. Epub 2016 Mar 31.
4
Comprehensive genomic analysis of malignant pleural mesothelioma identifies recurrent mutations, gene fusions and splicing alterations.恶性胸膜间皮瘤的全面基因组分析鉴定出复发性突变、基因融合和剪接改变。
Nat Genet. 2016 Apr;48(4):407-16. doi: 10.1038/ng.3520. Epub 2016 Feb 29.
5
Bap1 Is a Bona Fide Tumor Suppressor: Genetic Evidence from Mouse Models Carrying Heterozygous Germline Bap1 Mutations.Bap1是一种真正的肿瘤抑制因子:来自携带杂合性生殖系Bap1突变的小鼠模型的遗传学证据。
Cancer Res. 2016 May 1;76(9):2836-44. doi: 10.1158/0008-5472.CAN-15-3371. Epub 2016 Feb 19.
6
Targeting hypoxic response for cancer therapy.靶向缺氧反应用于癌症治疗。
Oncotarget. 2016 Mar 22;7(12):13464-78. doi: 10.18632/oncotarget.7229.
7
ENOX2-based early detection (ONCOblot) of asbestos-induced malignant mesothelioma 4-10 years in advance of clinical symptoms.基于ENOX2的早期检测(ONCOblot)可在石棉诱发的恶性间皮瘤出现临床症状前4至10年进行检测。
Clin Proteomics. 2016 Jan 22;13:2. doi: 10.1186/s12014-016-9103-3. eCollection 2016.
8
HMGB1 and Its Hyperacetylated Isoform are Sensitive and Specific Serum Biomarkers to Detect Asbestos Exposure and to Identify Mesothelioma Patients.高迁移率族蛋白B1及其超乙酰化异构体是检测石棉暴露和识别间皮瘤患者的敏感且特异的血清生物标志物。
Clin Cancer Res. 2016 Jun 15;22(12):3087-96. doi: 10.1158/1078-0432.CCR-15-1130. Epub 2016 Jan 5.
9
Bevacizumab for newly diagnosed pleural mesothelioma in the Mesothelioma Avastin Cisplatin Pemetrexed Study (MAPS): a randomised, controlled, open-label, phase 3 trial.贝伐珠单抗治疗新诊断的胸膜间皮瘤的 Mesothelioma Avastin Cisplatin Pemetrexed 研究(MAPS):一项随机、对照、开放标签、3 期临床试验。
Lancet. 2016 Apr 2;387(10026):1405-1414. doi: 10.1016/S0140-6736(15)01238-6. Epub 2015 Dec 21.
10
Combined Genetic and Genealogic Studies Uncover a Large BAP1 Cancer Syndrome Kindred Tracing Back Nine Generations to a Common Ancestor from the 1700s.基因与系谱学联合研究发现一个可追溯至18世纪一位共同祖先的九代庞大BAP1癌症综合征家族。
PLoS Genet. 2015 Dec 18;11(12):e1005633. doi: 10.1371/journal.pgen.1005633. eCollection 2015 Dec.

恶性间皮瘤:是时候进行翻译了吗?

Malignant Mesothelioma: Time to Translate?

作者信息

Napolitano Andrea, Carbone Michele

机构信息

Department of Thoracic Oncology, University of Hawai i Cancer Center, 96826 Honolulu, HI, USA.

出版信息

Trends Cancer. 2016 Sep;2(9):467-474. doi: 10.1016/j.trecan.2016.07.004.

DOI:10.1016/j.trecan.2016.07.004
PMID:28603777
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5461959/
Abstract

Malignant mesothelioma is an aggressive cancer largely associated with asbestos exposure. In this review, we will discuss the significant advancements in our understanding of its genetics and molecular biology and their translational relevance. Remarkable findings included the discovery of germline and somatic mutations of BRCA1 associated protein-1 (BAP1) in patients, and the genome-wide characterization of pathways altered in mesothelioma that could be potentially exploited to design novel therapeutic approaches. Nevertheless, the clinical translation of these molecular findings has been slow and insufficient. In order to rapidly move translation from the bench to the bedside, we believe that cooperative research efforts have to be further endorsed and promoted at all levels.

摘要

恶性间皮瘤是一种侵袭性癌症,主要与接触石棉有关。在本综述中,我们将讨论在其遗传学和分子生物学理解方面取得的重大进展及其转化相关性。显著的发现包括在患者中发现BRCA1相关蛋白-1(BAP1)的种系和体细胞突变,以及对间皮瘤中改变的通路进行全基因组表征,这些通路有可能被用于设计新的治疗方法。然而,这些分子发现的临床转化一直缓慢且不足。为了迅速将研究从实验室转化到临床应用,我们认为必须在各级进一步支持和推动合作研究工作。